author-photo

Laura Danielson

Institute of Cancer Research

13

Papers

198

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

In vivo modelling of chemo-resistant neuroblastoma provides new insights into chemo-refractory disease and metastasis.

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (17)
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma

2019 Endocrine-related Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibition

2018 Brain
Show All
- Source
- Cite
- Save
Citations (11)
Preclinical transgenic and patient-derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma

2018 Brain Pathology
Show All
- Source
- Cite
- Save
Citations (13)
Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma.

2017 Molecular Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Molecular profiling and preclinical targeted therapeutic testing in adamantinomatous craniopharyngioma

2017 The Lancet
Show All
- Source
- Cite
- Save
Citations (2)
PCM-02A GENETICALLY ENGINEERED MOUSE MODEL RECAPITULATES RADIOLOGICAL FEATURES OF HUMAN ADAMANTINOMATOUS CRANIOPHARYNGIOMA

2016 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.

2016 Disease Models & Mechanisms
Show All
- Source
- Cite
- Save
Citations (56)
Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (21)
Abstract B34: Antitumor activity and sensitivity evaluation of novel BET inhibitors in neuroblastoma

2015 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)